Showing results (141-150 of 41,938) with videos related to
Sort By:
Pageof 4,194
Praxis Der Kinderpsychologie Und Kinderpsychiatrie|January 21, 2020
[Mentalizing as a Mechanism of Change in the Therapy of Conduct Disorder. A Controlled Case Study]Lea A Kornhas, Max Zettl, Sophie Hauschild, et al.Current Biology : CB|May 28, 2013
WIP provides an essential link between Nck and N-WASP during Arp2/3-dependent actin polymerizationSara K Donnelly, Ina Weisswange, Markus Zettl, et al.European Neurology|October 29, 2018
Headache at the Time of First Symptom Manifestation of Multiple Sclerosis: A Prospective, Longitudinal StudyMarcel Gebhardt, Peter Kropp, Frank Hoffmann, et al.Frontiers in Immunology|April 30, 2019
The Cerebrospinal Fluid in Multiple SclerosisFlorian Deisenhammer, Henrik Zetterberg, Brit Fitzner, et al.Current Pharmaceutical Design|May 23, 2012
An inventory of short term and long term changes in gene expression under interferon β treatment of relapsing remitting MS patientsBrigitte K Paap, Alexander Hundeshagen, Michael Hecker, et al.Archives of Orthopaedic and Trauma Surgery|August 1, 2016
Short- and long-term outcomes following hallux-valgus correction: a modified Kramer osteotomyChristoph Knoth, Leonie Carow, Ralph Zettl, et al.American Journal of Clinical Pathology|May 22, 2007
Enteropathy-type T-cell lymphomaAndreas Zettl, Ron deLeeuw, Eugenia Haralambieva, et al.Der Nervenarzt|October 20, 2009
[Vaccination and multiple sclerosis]M Löbermann, A Winkelmann, E C Reisinger, et al.CNS Neuroscience & Therapeutics|June 3, 2018
Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal periodAlexander Winkelmann, Paulus Stefan Rommer, Michael Hecker, et al.Clinical and Experimental Immunology|September 5, 2013
Monoclonal antibodies in treatment of multiple sclerosisP S Rommer, A Dudesek, O Stüve, et al.Pageof 4,194